Exelixis Ownership | Who Owns Exelixis?
Exelixis Ownership Summary
Exelixis is owned by 80.97% institutional investors, 1.67% insiders, and 17.36% retail investors. Blackrock is the largest institutional shareholder, holding 11.14% of EXEL shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.14% of its assets in Exelixis shares.
EXEL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Exelixis | 80.97% | 1.67% | 17.36% |
Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 33.50M | 11.14% | $752.80M |
Vanguard group | 29.65M | 9.86% | $666.33M |
Farallon capital management | 27.10M | 9.01% | $608.99M |
Renaissance | 15.16M | 5.04% | $340.71M |
State street | 12.60M | 4.19% | $283.16M |
Lsv asset management | 5.76M | 1.92% | $129.51M |
Geode capital management | 5.17M | 1.72% | $116.11M |
Dimensional fund advisors lp | 5.14M | 1.71% | $115.43M |
Jpmorgan chase | 5.05M | 1.68% | $113.45M |
Nuveen asset management | 4.05M | 1.35% | $91.04M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Meditor group | 1.75M | 72.86% | $39.39M |
Krensavage asset management | 1.68M | 17.31% | $37.69M |
Caligan partners lp | 1.53M | 8.01% | $34.28M |
13d management | 360.01K | 5.90% | $8.09M |
Findell capital management | 500.00K | 5.42% | $11.23M |
Farallon capital management | 27.10M | 2.87% | $608.99M |
Lingohr & partner asset management gmbh | 31.99K | 1.80% | $719.00K |
Nan fung group | 64.20K | 1.54% | $1.44M |
Capital management corp /va | 339.92K | 1.53% | $7.64M |
Kepos capital lp | 175.00K | 1.53% | $3.93M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Lsv asset management | 5.76M | 0.28% | 2.99M |
Norges bank | 2.79M | 0.01% | 2.79M |
Arrowstreet capital, limited partnership | 1.20M | 0.02% | 776.03K |
Qube research | 480.58K | 0.02% | 464.50K |
Caligan partners lp | 1.53M | 8.01% | 425.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Morgan stanley | 2.28M | 0.00% | -2.41M |
Los angeles capital management | 799.36K | 0.06% | -1.65M |
Brandywine global investment management | - | - | -1.47M |
Price t rowe associates inc /md/ | 1.95M | 0.01% | -1.39M |
Blackrock | 33.50M | 0.02% | -1.38M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 2.79M | 0.01% | 2.79M | $62.67M |
Corebridge financial | 371.32K | 0.05% | 371.32K | $8.34M |
Two seas capital lp | 111.30K | 0.41% | 111.30K | $2.50M |
Van eck associates | 104.45K | 0.00% | 104.45K | $2.35M |
Millennium management | 103.20K | 0.00% | 103.20K | $2.32M |
Sold Out
Holder | Change |
---|---|
Tfo-tdc | -1.00 |
Financial gravity asset management | -2.00 |
Financial synergies wealth advisors | -10.00 |
Avion wealth | -22.00 |
Highmark wealth management | -51.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 428 | -2.95% | 243,518,464 | -2.42% | 80 | 1.18% | 176 | -6.38% | 172 | 2.38% |
Mar 31, 2024 | 441 | -0.68% | 249,560,241 | -3.26% | 82 | 1.26% | 188 | -12.15% | 168 | 10.53% |
Dec 31, 2023 | 444 | 8.29% | 257,978,506 | -1.23% | 81 | 1.18% | 214 | 16.94% | 152 | 2.70% |
Sep 30, 2023 | 410 | 4.86% | 261,178,991 | -4.42% | 82 | 1.17% | 183 | 13.66% | 148 | -1.99% |
Jun 30, 2023 | 391 | 3.99% | 273,262,470 | -2.53% | 84 | 1.13% | 161 | -6.94% | 151 | 18.90% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Mid-Cap ETF | 8.98M | 3.14% | 4.86K |
Vanguard Total Stock Mkt Idx Inv | 8.60M | 3.01% | -32.55K |
Vanguard Small Cap Index | 6.80M | 2.38% | 13.30K |
Vanguard Institutional Extnd Mkt Idx Tr | 4.27M | 1.49% | -201.58K |
Vanguard Small Cap Growth Index Inv | 3.73M | 1.31% | -9.29K |
Vanguard Explorer Inv | 2.85M | 1.00% | - |
SPDR® S&P Biotech ETF | 2.44M | 0.85% | 26.99K |
Stephens SMID Select Growth | 2.27M | 0.80% | 8.47K |
SPDR® S&P MIDCAP 400 ETF Trust | 2.24M | 0.79% | -33.03K |
JPM US Mid Cap Growth-Composite | 2.18M | 0.76% | -386.43K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 05, 2024 | Aftab Dana | CSO/EVP Disc & Trans Research | Sell | $3.39M |
Nov 01, 2024 | Hessekiel Jeffrey | EVP & General Counsel | Sell | $1.71M |
Nov 01, 2024 | POSTE GEORGE | - | Sell | $1.02M |
Oct 30, 2024 | Aftab Dana | CSO/EVP Disc & Trans Research | Sell | $36.49K |
Oct 28, 2024 | Hessekiel Jeffrey | EVP & General Counsel | Sell | $709.75K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 5 |
2024 Q3 | - | 9 |
2024 Q2 | 2 | 5 |
2024 Q1 | 1 | 2 |
2023 Q4 | 1 | 6 |
EXEL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools